Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
The current study is the result of a collaborative effort between scientists at the Department of Clinical Science and Education, the Stockholm South General Hospital (Södersjukhuset), and the pharmaceutical company Boehringer Ingelheim Pharma GmbH & Co. The work was conceived and directed by Dr Cesare Patrone and Professor Åke Sjöholm, while Dr Vladimer Darsalia led the experiments of the study.
Publication: 'The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain: a comparison with glimepiride', Vladimer Darsalia, Henrik Ortsäter, Anna Olverling, Emilia Darlöf, Petra Wolbert, Thomas Nyström, Thomas Klein, Åke Sjöholm, and Cesare Patrone, Diabetes, online 4 December 2012.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Stroke category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Institutet, Karolinska. "Linagliptin For Diabetes May Reduce Brain Damage After Stroke." Medical News Today. MediLexicon, Intl., 5 Dec. 2012. Web.
10 Mar. 2014. <http://www.medicalnewstoday.com/releases/253548>
Institutet, K. (2012, December 5). "Linagliptin For Diabetes May Reduce Brain Damage After Stroke." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/253548.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.